Skip Navigation

Europace 1999 1(1):40-42; doi:10.1053/eupc.1998.0005
© 1999 by European Society of Cardiology
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gillis, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gillis, A. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The Atrial Pacing Peri-ablation for Paroxysmal Atrial Fibrillation (PA3) Study

Rationale and study design

A. M. Gillis

Division of Cardiology, Foothills Hospital and The University of Calgary Calgary, Alberta, Canada

The Canadian Atrial Pacing Peri-Ablation for Paroxysmal Atrial Fibrillation Study tested the hypotheses that atrial pacing prevents paroxysmal atrial fibrillation (PAF) in patients without symptomatic bradycardia and that DDDR pacing is more likely to prevent PAF following total atrioventricular (AV) node ablation compared to VDD pacing. Patients with PAF who were refractory to or intolerant of antiarrhythmic drug therapy received a Medtronic Thera DR pacemaker 3 months prior to a planned total AV node ablation. Patients were randomized to atrial pacing or no pacing therapy. The time to first recurrence of sustained PAF was the primary study outcome event. Following AV node ablation, patients were randomized to the DDDR or VDD mode in a crossover study design. Patients were followed in each mode for 6 months. The time course of PAF recurrence was compared for each pacing mode.

Key Words: Paroxysmal atrial fibrillation, atrial pacing, dual chamber pacing, ventricular pacing, rate-responsive pacing

Correspondence: Anne M. Gillis, MD, FRCPC, Division of Cardiology, The University of Calgary, 3330 Hospital Drive N.W., Calgary, Alberta, Canada T2N 4N1.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 EuropaceHome page
W. de Voogt, N. van Hemel, P. de Vusser, G. H. Mairesse, R. van Mechelen, J. Koistinen, A. van den Bos, I. Roose, J. Voitk, S. Yli-Mayry, et al.
No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation
Europace, September 1, 2007; 9(9): 798 - 804.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
M. Brignole, M. Gammage, L. Jordaens, R. Sutton, and on behalf of the Barcelona Discussion Group
Report of a study group on ablate and pace therapy for paroxysmal atrial fibrillation
Europace, January 1, 1999; 1(1): 8 - 13.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.